CORCORAN & ASSOCIATES, INC. DBA CORCORAN PARTNERS

Lobbying for ORCHARD THERAPEUTICS NORTH AMERICA · Health

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate · $30,000.00 income · posted Apr 20, 2026

Lobbying activity 2

Health Issues

Metachromatic Leukodystrophy included on Recommended Uniform Screening Panel (RUSP) Metachromatic Leukodystrophy treatment

Budget/Appropriations

Funding for implementation of Recommended Uniform Screening Panel (RUSP)

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.